PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

August 6th, 2009 Issue 37 Vol. 6
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Lilly offers to ‘Make a Deal’ with Reps
The drug giant announced a plan to offer buyouts to 4,000 sales representatives in an effort to trim its bloated sales force without resorting to layoffs
» MORE

FDA Strengthens TNF Blocker Labels
TNF Blockers, such as Remicade, Enbrel, and Humira will now contain warnings for lymphoma in children. That’s on top of the cancer warnings already included on these top cancer meds
» MORE

Avastin Gets Green Light for Use in Kidney Cancer
Genentech, now owned entirely by Roche, announced that FDA had approved Avastin for kidney cancer
» MORE

Wyeth Hired Ghostwriters for HRT Articles
Writers paid by the pharma giant helped produce 26 scientific papers published in medical journals that backed the use of hormone replacement therapy in women
» MORE

New Strain of H.I.V. Is Discovered
A new strain of the virus that causes AIDS has been discovered in a woman from the African nation of Cameroon
» MORE

PharmRep Direct Features

Video Games: Key to the Future of Healthcare?
Initial survey and results suggest that health games and virtual worlds bear the potential to be “game changers” by improving education, provoking greater engagement, and engendering positive behavior to enhance health and wellness.
» MORE

Pharma Tackles Tropical Diseases
The pharmaceutical industry is paying more attention to less well-known tropical diseases, according to a report from the International Federation of Pharmaceutical Manufacturers & Associations
» MORE

Doctors Grapple with Impact of Recession

As the recession squeezes practices, physicians are searching for ways to cut costs and raise revenues
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Survey, Vote Today!
How much do state regulations impact your ability to talk with doctors?
Click Here to Vote

PharmRep Direct Quick Links
FDA Approves New Statin

Bing Criticized For Pharmacy Ads

Pfizer, PhRMA Lobby Hard



You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!